tiprankstipranks
Advertisement
Advertisement

GMAB Stock Latest News

Genmab price target raised to $40 from $38 at H.C. Wainwright
The FlyGenmab price target raised to $40 from $38 at H.C. Wainwright
3h ago
GMAB
Blair adds American Express, Oracle to Conviction List in monthly update
PremiumThe Fly
Blair adds American Express, Oracle to Conviction List in monthly update
1d ago
P
CW
PremiumRatings
Genmab: Buy Rating Reiterated on Strong Epkinly Phase III Data and Late-Stage Pipeline; Price Target Unchanged at DKK 2,500
2d ago
GMAB
Genmab: Strong Phase III EPCORE DLBCL-4 Data and Major Label Expansion Opportunity Reinforce Buy Rating
PremiumRatings
Genmab: Strong Phase III EPCORE DLBCL-4 Data and Major Label Expansion Opportunity Reinforce Buy Rating
2d ago
GMAB
Genmab Reports Strong Phase 3 Data for Epcoritamab Combo in Relapsed/Refractory DLBCL
PremiumCompany Announcements
Genmab Reports Strong Phase 3 Data for Epcoritamab Combo in Relapsed/Refractory DLBCL
3d ago
6K
GMAB
Genmab announces topline results from EPCORE DLBCL-4 trial
PremiumThe FlyGenmab announces topline results from EPCORE DLBCL-4 trial
3d ago
ABBV
GMAB
Genmab reports ‘positive’ Phase 3 results from EPCORE DLBCL-4 trial
Premium
The Fly
Genmab reports ‘positive’ Phase 3 results from EPCORE DLBCL-4 trial
3d ago
GMAB
AbbVie reports ‘positive’ results from Phase 3 EPCORE DLBCL-4 trial
Premium
The Fly
AbbVie reports ‘positive’ results from Phase 3 EPCORE DLBCL-4 trial
3d ago
ABBV
GMAB
Ram Selvaraju Reiterates Buy on Genmab, Keeps EPKINLY-Driven Outlook with Unchanged $38 Price Target
PremiumRatings
Ram Selvaraju Reiterates Buy on Genmab, Keeps EPKINLY-Driven Outlook with Unchanged $38 Price Target
9d ago
GMAB
Genmab Updates Articles of Association, Extends Capital-Raising Powers
PremiumCompany Announcements
Genmab Updates Articles of Association, Extends Capital-Raising Powers
15d ago
6K
GMAB
Genmab Announces Minor Capital Increase Following Employee Warrant Exercise
PremiumCompany Announcements
Genmab Announces Minor Capital Increase Following Employee Warrant Exercise
16d ago
6K
GMAB
Genmab Discloses Orbis as New 4.99% Major Shareholder
PremiumCompany Announcements
Genmab Discloses Orbis as New 4.99% Major Shareholder
17d ago
6K
GMAB
Genmab Updates Articles of Association to Expand Capital-Raising Flexibility
PremiumCompany AnnouncementsGenmab Updates Articles of Association to Expand Capital-Raising Flexibility
17d ago
6K
GMAB
Matt Phipps Reiterates Buy on Genmab as Strong Epkinly Data Offset Missed Overall Survival Endpoint and Support Long-Term Upside
Premium
Ratings
Matt Phipps Reiterates Buy on Genmab as Strong Epkinly Data Offset Missed Overall Survival Endpoint and Support Long-Term Upside
17d ago
GMAB
Genmab announces new data from studies evaluating epcoritamab
Premium
The Fly
Genmab announces new data from studies evaluating epcoritamab
18d ago
GMAB
Genmab Grants New Restricted Stock Units and Warrants to Employees
PremiumCompany Announcements
Genmab Grants New Restricted Stock Units and Warrants to Employees
21d ago
6K
GMAB
Genmab Trial Setback: Terminated Melanoma Study Adds Uncertainty to GMAB’s Immuno-Oncology Outlook
PremiumCompany Announcements
Genmab Trial Setback: Terminated Melanoma Study Adds Uncertainty to GMAB’s Immuno-Oncology Outlook
21d ago
GMAB
Genmab presents EPCORE FL-1 subgroup data at EHA 2026 Congress
PremiumThe Fly
Genmab presents EPCORE FL-1 subgroup data at EHA 2026 Congress
21d ago
GMAB
Genmab Advances Rina-S Into Phase 3 Ovarian Cancer Trial, Setting Up a New Long-Term Catalyst
PremiumCompany Announcements
Genmab Advances Rina-S Into Phase 3 Ovarian Cancer Trial, Setting Up a New Long-Term Catalyst
29d ago
GMAB
Genmab Expands Rina-S Ovarian Cancer Program in China, Raising Long-Term Upside Potential
PremiumCompany AnnouncementsGenmab Expands Rina-S Ovarian Cancer Program in China, Raising Long-Term Upside Potential
30d ago
GMAB
Genmab Reports Board Member Share Sale Under EU Market Abuse Rules
Premium
Company Announcements
Genmab Reports Board Member Share Sale Under EU Market Abuse Rules
1M ago
6K
GMAB
Genmab assumed with a Buy at Truist
Premium
The Fly
Genmab assumed with a Buy at Truist
1M ago
GMAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >